Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy
Clinical trial NCT04800978 · UNKNOWN
Trial details
- NCT number
- NCT04800978
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-14
- Primary completion
- 2024-08-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.